AMRI CEO to Present at 28th Annual J.P. Morgan Healthcare Conference

AMRI (NASDAQ: AMRI) announced today that AMRI Chairman, President and Chief Executive Officer Thomas E. D’Ambra, Ph.D. will present at the 28^th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 14, 2010 at 1:30 p.m. PT.

An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company’s website at www.amriglobal.com. A replay of the webcast will be available within three hours after the live webcast through February 15, 2010.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.